Autoimmune diseases afflict 45 million Americans—and it requires a collective community effort to change that.

Our new Community Quest video shows how investors, innovators, regulators, patients, insurers—and you—make new treatments possible, accessible, and affordable.

Anyone with questions about drug pricing, investment in innovation, insurance…

There is now an AI you can speak with:
www.nopatientleftbehind.org/chat-nplb

Give it a spin. Call out what you think it gets wrong. (That’s one of the exercises in the NPLB fellowship, actually).

No Patient Left Behind steps up again
@nplb.bsky.social

Video from many #biotech leaders to #Trump on addressing international freeriding (others paying less than US for meds).

Learn why “Most Favored Nation” policy backfires… and a better approach.

www.nopatientleftbehind.org/protect-amer...

Do you serve on a biotech board? Wish meetings were clearer, shorter, focused on strategy?

You’ll love RA Capital’s Gateway (gateway.racap.com), a resource for execs/directors.

Insights from peers. Used by thousands. Eg. Core value propositions & elephant slides. Role of chair. Price discovery

Rfk Jr & vaccine “skeptics” mislead when they say vaccines haven’t been tested vs placebo. The first vaccine of every kind is absolutely tested vs placebo. When it works, it’s unethical to test future versions vs placebo. Those are tested vs prior version. If better, then also better than placebo.

Reposting for the Harvard Biotech Club members who are joining now for the podcast recording.

Flying back from JPM? Watch this. Congressman Jake Auchincloss knows more about what’s wrong with healthcare, PBMs, drug value assessment, & pricing policy than most executives. Biocentury’s @steveusdin.bsky.social interview surfaces issues all execs need to know.

www.youtube.com/watch?v=w-Ji...

Biotech on Bluesky get a look first.

RA Capital’s annual thoughts on how biotech can better (Semper Maior; always better). This one explore how we can elicit more candor. Some stories, too.

And tons of top-down data analyzing 2024 performance & setup for 2025.

rapport.bio/all-stories/...

Biotech on Bluesky, I’m sharing with you first.

RA Capital just launched Biotech Unveiled, a free online course our team created.

Learn at own pace. Covers fundamentals of how insurance + investment direct R&D. Essential knowledge for leaders.

racap.thinkific.com/courses/biot...

The interesting thing about Bluesky is watching something like the Wild West open up.

Who knows if it ever becomes as populated as Twitter, but in these early days, you see how a platform takes shape.

For example, notice the ratio of followers to posts… it seems a sign of how… 1/4

As a virologist, I encourage everyone to listen to @scottgottliebmd.bsky.social’s advice on preparing for possible flu pandemic. As an investor, I hope US makes appropriate investments.

We have better tools now than we did for COVID. Diff virus, diff tools.

www.washingtonpost.com/opinions/202...

My whole career (scientist/VC) there were diseases that I thought I might never be cracked.

Alzheimer’s was one. Now seeing signs of progress.

Lupus was another, now cracking. I think it’s curable.

What diseases would you want to see cured?

Scientists here can add if they feel optimistic.

What was an investor’s real reason for passing? What do they know? Might that info help a company?

Yet, there’s a downside to candor. Feelings may get hurt. Investors get ghosted on deal.

How might we flip it so there’s upside?

Insights from #biotech & any sector welcome.

Every Xmas, those of us who are w/ our families appreciate all who work to keep the world running. Store clerks, nurses, police, public utility workers…

…and, did you know, in the drug industry, many scientists & technicians keep experiments running & medicines in production.

Thank you all :)

I’m involved with No Patient Left Behind’s fellowship program www.nopatientleftbehind.org

When students ask me for career advice, I often share the same stories & suggestions.

Here’s what I say. (This is long)…

Super informative article from @peterkolchinsky.bsky.social covering the health economics of Vertex’s Nav1.8 inhibitor VX-548/suzetrigine rapport.bio/all-stories/...

Love my bookshop; take my kids there to buy books b/c great experience. If it weren’t, I wouldn’t support just to keep them employed.

Amazon is great, too (covid!). Even if it displaced bookshops, people would do something else society valued.

Imagine shunning cars to support carriage drivers.

Healthcare costs are high, but there's an 8% slice that does more than anything to improve our lives & drive down costs.

If drug prices come up during TG dinner, you’ll win w/these points ;)

@phrma.bsky.social @naturebiotech.bsky.social
#biotech

@nplb.bsky.social

rapport.bio/all-stories/...